Scorpion Therapeutics, Inc. — Form D

Scorpion Therapeutics, Inc. of Boston, MA, a company, filed a Form D exempt-offering notice with the SEC on 2020-12-07. $147.0M was reported sold. Industry: Biotechnology.

Offering

Issuer

Officers, directors & promoters (24)

NameRoleLocation
Shelley Joseph ChuDirectorBoston, MA
Keith Joseph FlahertyDirectorBoston, MA
Jean-Francois Joseph FormelaDirectorBoston, MA
Gary GlickDirectorLONDON, X0
Arjun Joseph GoyalDirectorBoston, MA
Otello Joseph StampacchiaDirectorBoston, MA
Peter Joseph Campisi, Jr.Executive OfficerBoston, MA
Gary GlickExecutive OfficerLONDON, X0
Shelley ChuDirectorLexington, MA
Otello StampacchiaDirectorBoston, MA
Jean-Francois FormelaDirectorCambridge, MA
Andrew FedderExecutive OfficerBoston, MA
Jeffrey AlbersDirectorBoston, MA
Keith FlahertyDirectorBoston, MA
Adam FriedmanDirectorBoston, MA
Adam FriedmanExecutive OfficerBoston, MA
Brian PiperExecutive OfficerBoston, MA
Oleg NodelmanDirectorSan Francisco, CA
Arjun GoyalDirectorWatertown, MA
Darrin StuartExecutive OfficerBoston, MA
Erica JacksonExecutive OfficerBoston, MA
Amanda ValentinoExecutive OfficerBoston, MA
Saurabh SahaDirectorBoston, MA
Mark ChaoExecutive OfficerBoston, MA

Other filings by this issuer (2)

FiledFormOfferingSold
2024-07-16D$150.0M$125.7M
2020-05-19D$24.7M

More